Martin Turner studied Biochemistry at UCL and did his PhD with Professor Sir Marc Feldmann in London. He worked with Victor Tybulewicz at the MRC National Âé¶¹ÊÓÆµ for Medical Research where he identified key signal transduction pathways for B and T lymphocytes. He has been at the BBSRC’s Babraham Âé¶¹ÊÓÆµ since 1997. He has uncovered key roles for PI3K in lymphocyte signalling and development. He is interested in RNA-binding proteins and MicroRNAs and how these function within signal transduction networks and DNA transcription factor networks to control cell differentiation and immunity.